Literature DB >> 9368258

Design and methods of the National Cooperative Inner-City Asthma Study.

H Mitchell1, Y Senturia, P Gergen, D Baker, C Joseph, K McNiff-Mortimer, H J Wedner, E Crain, P Eggleston, R Evans, M Kattan, C Kercsmar, F Leickly, F Malveaux, E Smartt, K Weiss.   

Abstract

The National Cooperative Inner-City Asthma Study (NCICAS) was established to identify and then intervene on those factors which are related to asthma morbidity among children in the inner-city. This paper describes the design and methods of the broad-based initial Phase I epidemiologic investigation. Eight research centers enrolled 1,528 children, 4 to 9 years of age, from English- or Spanish-speaking families, all of whom resided in major metropolitan inner-city areas. The protocol included an eligibility assessment and an extensive baseline visit, during which symptom data, such as wheezing, lost sleep, changes in activities of daily living, inpatient admissions, and emergency department and clinic visits were collected. A comprehensive medical history for each child was taken and adherence to the medical regimen was assessed. Access, as well as barriers, to the medical system were addressed by a series of questions including the location, availability, and consistency of treatment for asthma attacks, follow-up care, and primary care. The psychological health of the caretaker and of the child was also measured. Asthma knowledge of the child and caretaker was determined. Sensitization to allergens was assessed by skin-prick allergen testing and exposure to cigarette smoke and the home environment were assessed by questionnaire. For more than a third of the families, in-home visits were conducted with dust sample allergen collection and documentation of the home environment, such as the presence of pets and evidence of smoking, mildew, and roaches. Urine specimens were collected to measure passive smoke exposure by cotinine assays, blood samples were drawn for banking, and children age 6 to 9 years were given spirometric lung function assessment. At 3, 6 and 9 months following the baseline assessment, telephone interviews were conducted to ask about the child's symptoms, unscheduled emergency department or clinic visits, and hospitalizations. At this time, peak flow measurements with 2-week diary symptom records were collected.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9368258     DOI: 10.1002/(sici)1099-0496(199710)24:4<237::aid-ppul3>3.0.co;2-h

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  48 in total

Review 1.  Review of psychosocial stress and asthma: an integrated biopsychosocial approach.

Authors:  R J Wright; M Rodriguez; S Cohen
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

Review 2.  Environmental Food Exposure: What Is the Risk of Clinical Reactivity From Cross-Contact and What Is the Risk of Sensitization.

Authors:  William J Sheehan; Steve L Taylor; Wanda Phipatanakul; Helen A Brough
Journal:  J Allergy Clin Immunol Pract       Date:  2018 Nov - Dec

Review 3.  Interventions for educating children who are at risk of asthma-related emergency department attendance.

Authors:  Michelle Boyd; Toby J Lasserson; Michael C McKean; Peter G Gibson; Francine M Ducharme; Michelle Haby
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

4.  The School Inner-City Asthma Intervention Study: Design, rationale, methods, and lessons learned.

Authors:  Wanda Phipatanakul; Petros Koutrakis; Brent A Coull; Choong-Min Kang; Jack M Wolfson; Stephen T Ferguson; Carter R Petty; Mihail Samnaliev; Amparito Cunningham; William J Sheehan; Jonathan M Gaffin; Sachin N Baxi; Peggy S Lai; Perdita Permaul; Liming Liang; Peter S Thorne; Gary Adamkiewicz; Kasey J Brennan; Andrea A Baccarelli; Diane R Gold
Journal:  Contemp Clin Trials       Date:  2017-06-12       Impact factor: 2.226

5.  Proximity to major roadways and asthma symptoms in the School Inner-City Asthma Study.

Authors:  Marissa Hauptman; Jonathan M Gaffin; Carter R Petty; William J Sheehan; Peggy S Lai; Brent Coull; Diane R Gold; Wanda Phipatanakul
Journal:  J Allergy Clin Immunol       Date:  2019-09-23       Impact factor: 10.793

6.  The school inner-city asthma study: design, methods, and lessons learned.

Authors:  Wanda Phipatanakul; Anne Bailey; Elaine B Hoffman; William J Sheehan; Jeffrey P Lane; Sachin Baxi; Devika Rao; Perdita Permaul; Jonathan M Gaffin; Christine A Rogers; Michael L Muilenberg; Diane R Gold
Journal:  J Asthma       Date:  2011-10-20       Impact factor: 2.515

7.  Mouse allergens in urban elementary schools and homes of children with asthma.

Authors:  William J Sheehan; Pitud A Rangsithienchai; Michael L Muilenberg; Christine A Rogers; Jeffrey P Lane; Jalal Ghaemghami; Donald V Rivard; Kanao Otsu; Elaine B Hoffman; Elliot Israel; Diane R Gold; Wanda Phipatanakul
Journal:  Ann Allergy Asthma Immunol       Date:  2009-02       Impact factor: 6.347

8.  Impulse oscillometry versus spirometry in a long-term study of controller therapy for pediatric asthma.

Authors:  Gary L Larsen; Wayne Morgan; Gregory P Heldt; David T Mauger; Susan J Boehmer; Vernon M Chinchilli; Robert F Lemanske; Fernando Martinez; Robert C Strunk; Stanley J Szefler; Robert S Zeiger; Lynn M Taussig; Leonard B Bacharier; Theresa W Guilbert; Shelley Radford; Christine A Sorkness
Journal:  J Allergy Clin Immunol       Date:  2008-12-12       Impact factor: 10.793

9.  Prenatal and postnatal bisphenol A exposure and asthma development among inner-city children.

Authors:  Kathleen M Donohue; Rachel L Miller; Matthew S Perzanowski; Allan C Just; Lori A Hoepner; Srikesh Arunajadai; Stephen Canfield; David Resnick; Antonia M Calafat; Frederica P Perera; Robin M Whyatt
Journal:  J Allergy Clin Immunol       Date:  2013-03       Impact factor: 10.793

10.  Effect of environmental intervention on mouse allergen levels in homes of inner-city Boston children with asthma.

Authors:  Wanda Phipatanakul; Beth Cronin; Robert A Wood; Peyton A Eggleston; Mei-Chiung Shih; Leslie Song; Raffi Tachdjian; Hans C Oettgen
Journal:  Ann Allergy Asthma Immunol       Date:  2004-04       Impact factor: 6.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.